Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

AdvaMed Tells US FDA Which Guidelines Need To Be Finalized First

This article was originally published in Clinica

Executive Summary

US medtech trade group AdvaMed is calling on the Food and Drug Administration to prioritize completing five of the 12 final guidelines that the agency said it intends to complete in fiscal year 2016, including guidelines on medical device accessories and unique device identification (UDI) direct marking.